EG434008 inhibitors are a class of chemical compounds specifically designed to inhibit the activity of the EG434008 molecule, which is likely involved in key regulatory functions within cellular signaling or enzymatic pathways. Although the precise role of EG434008 may vary, it is assumed to play a critical part in modulating biochemical interactions, potentially influencing processes such as protein function, metabolic regulation, or signal transduction. By targeting and inhibiting EG434008, these inhibitors disrupt its normal activity, leading to changes in the cellular pathways it regulates. Such inhibition provides a valuable tool for understanding the molecular mechanisms controlled by EG434008 and its contribution to the broader regulation of cellular processes and homeostasis.
Structurally, EG434008 inhibitors are crafted to bind to essential domains of the EG434008 molecule, typically its active site or regulatory regions that are crucial for its interaction with substrates or binding partners. Inhibitors may function through competitive inhibition by directly blocking the active site, thereby preventing EG434008 from engaging with its natural substrates. Alternatively, they may act through non-competitive inhibition, altering the structure of EG434008 to reduce its functional efficiency. The study of EG434008 inhibitors allows researchers to observe the downstream effects of inhibiting this molecule on interconnected biochemical networks. By examining how these inhibitors impact cellular signaling and metabolic pathways, researchers can gain deeper insights into how EG434008 contributes to cellular regulation, protein interactions, and overall molecular balance within the cell. This research helps unravel the complex roles played by such molecules in maintaining essential cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $50.00 $126.00 $246.00 $3500.00 | 7 | |
Nystatin, an antifungal agent, directly targets membrane integrity. By binding to ergosterol in fungal membranes, it disrupts membrane structure. While not specific to Tmem178b, its membrane-targeting property could potentially impact the activity or localization of transmembrane proteins like Tmem178b. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
Chlorpromazine, an antipsychotic, indirectly influences membrane-related processes. Its ability to modulate lipid bilayer properties may impact membrane protein function. Tmem178b, located in the membrane, could be influenced by changes in the lipid environment caused by chlorpromazine. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Dynasore inhibits dynamin, affecting clathrin-mediated endocytosis. As Tmem178b is a transmembrane protein, disrupting endocytic processes may indirectly impact its turnover or localization, potentially influencing its cellular functions. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Amiloride, a sodium channel blocker, directly targets ion transport. Given Tmem178b's membrane localization, changes in ion concentrations influenced by amiloride may impact its activity or function in membrane-associated processes. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase, affecting cholesterol biosynthesis. As Tmem178b is a transmembrane protein, alterations in membrane cholesterol levels could indirectly influence its function or localization, linking to the regulation of membrane properties. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits PI3-kinases, affecting membrane-related signaling pathways. Given Tmem178b's membrane activity, interference with PI3-kinase signaling may indirectly modulate its function or localization, connecting to processes influenced by membrane-associated signaling. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation in the endoplasmic reticulum. While not specific to Tmem178b, its impact on glycosylation may indirectly affect the processing or stability of membrane proteins, potentially influencing Tmem178b's cellular functions. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Cytochalasin D disrupts actin polymerization, impacting membrane dynamics. As Tmem178b is located in the membrane, alterations in actin cytoskeleton organization induced by cytochalasin D may indirectly influence its cellular functions or localization. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB inhibits IP3 receptors, influencing calcium signaling. Given Tmem178b's membrane activity, changes in calcium concentrations may indirectly modulate its function, linking to cellular processes associated with membrane-bound calcium signaling. | ||||||
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $114.00 $225.00 | 12 | |
Gossypol inhibits anti-apoptotic Bcl-2 proteins. While not directly related to Tmem178b, its impact on apoptosis and membrane integrity may indirectly influence cellular processes where Tmem178b participates, potentially affecting its function or localization. | ||||||